Menarini Group Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Menarini Group's estimated annual revenue is currently $2.6B per year.(i)
  • Menarini Group's estimated revenue per employee is $201,000

Employee Data

  • Menarini Group has 12694 Employees.(i)
  • Menarini Group grew their employee count by 7% last year.

Menarini Group's People

NameTitleEmail/Phone
1
Senior Brand ManagerReveal Email/Phone
2
Senior Business Manager - Rare DiseasesReveal Email/Phone
3
General ManagerReveal Email/Phone
4
Account Manager / EconomistReveal Email/Phone
5
Representante visitador médicoReveal Email/Phone
6
(Sr Dir) Global Real World Evidence & Epidemiology LeadReveal Email/Phone
7
Responsabile di ProduzioneReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is Menarini Group?

Manufacturing Biotechnology Center for the production of recombinant protein in Mammalian, Microrganism and yeast cells

keywords:N/A

N/A

Total Funding

12694

Number of Employees

$2.6B

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Menarini Group News

2022-04-19 - Hemoglobin A1c Testing Devices Market Size, Scope And ...

... Bio-Rad Laboratories Inc., Danaher Corporation, Menarini Group, F. Hoffmann-La Roche Ltd., Tosoh Corporation, Siemens Healthcare.

2022-04-17 - Hemoglobin A1c Testing Market Size And Forecast | Abbott ...

... Danaher Corporation (Beckman Coulter), F. Hoffmann-La Roche Ltd., Menarini Group, Sebia, Siemens Healthcare, Tosoh Corporation.

2022-04-17 - Global Avanafil Market 2022-2028 Business Analysis by Top ...

Menarini Group; Auxilium Pharmaceuticals; Endo International; JW Pharmaceutical. This record is divided into numerous distinct regions, one of...

2021-06-01 - Menarini Announces New SEL24/MEN1703 Clinical Data from DIAMOND-01 Trial USA - English USA - English France - Français Italia - Italiano Deutschland - Deutsch España - español

POMEZIA, Italy, June 1, 2021 /PRNewswire/ -- The Menarini Group announced today that additional data have been generated on SEL24/MEN1703, a first-in-class, orally available, dual PIM/FLT3 inhibitor, as part of the DIAMOND-01 trial. The results will be presented at both the upcoming American S ...

2021-04-09 - Menarini Pills of Art Junior project launched, video clips made by the younger generations for children and teenagers USA - English USA - English

Watchword: getting the younger generations talking about art. Following on from the success of the Menarini Pills of Art, with 18 million views worldwide, Menarini now launches the "junior" version, in which young art experts reply to the questions, and sometimes unexpected curiosities, childr ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5011.1M132577%N/A
#2
$2753.9M135662%N/A
#3
$5263.3M1363218%N/A
#4
$1930M13729N/AN/A
#5
$5221.3M138139%N/A